Stay invested in Sun Pharma: Sharmila Joshi

Sharmila Joshi of sharmilajoshi.com told CNBC-TV18, "A disclosure first that I do own Sun Pharmaceutical Industries and I continue to be positive on the stock. I do not think this is the price to sell the stock."

She further added, "You did not really see the stock crack below that Rs 620-625 level and now, we are seeing at Rs 500 odd levels. Today, for instance it is doing reasonably well because of that approval they got from US Food and Drug Administration (FDA). And it has rekindled hope that since they are getting approvals, slowly this will be a bottoming out process for the stock. So even if that may be true, maybe there is a little bit of a downside left and if you see it back at the lower levels that it made, it might be a good idea to add more. But definitely do stay invested."